• 一抗
  • 二抗
  • 慢病毒
  • 细胞系
  • 裂解物
  • 试剂类

WB-Validated BMAL1 Lentiviral shRNA Knockdown Kit #V63424

一键复制产品信息
RT-qPCR analysis. HeLa cells were infected with BMAL1-specific shRNA lentiviral particles, total RNA was extracted from wild-type and knockdown cells, RT-qPCR was performed using gene-specific primers. ∆Ct (CtKD-CtWT) was used to calculate mRNA reduction (%) between wild-type and knockdown cells using the following formula: (1-1/2∆Ct) x 100%.
Western blotting analysis. BMAL1 protein expression in wild-type (WT) and shRNA knockdown (KD) HeLa cells was detected using Western blotting. Hsp90 α served as a loading control. The blots were incubated with primary antibodies against BMAL1 and Hsp90 α, respectively, followed by incubating with HRP-conjugated goat anti-mouse secondary antibody. Images were developed using FeQ™ ECL Substrate Kit.
  • 基因名:
    BMAL1
  • 货号:
    V63424
  • 应用:
    Gene Knockdown (KD)
  • 物种反应性:
    H
规格:
1 Kit
价格:
8000
Information
Product Name WB-Validated BMAL1 Lentiviral shRNA Knockdown Kit
Aliases BMAL1; Basic Helix-Loop-Helix ARNT Like 1; BHLHe5; PASD3; MOP3; Brain And Muscle ARNT-Like 1; ARNTL1; ARNTL; JAP3; Aryl Hydrocarbon Receptor Nuclear Translocator-Like Protein 1; Aryl Hydrocarbon Receptor Nuclear Translocator Like; Basic Helix-Loop-Helix ARNT-Like Protein 1; Class E Basic Helix-Loop-Helix Protein 5; Basic Helix-Loop-Helix Family Member E5; Basic-Helix-Loop-Helix-PAS Protein MOP3; PAS Domain-Containing Protein 3; Member Of PAS Superfamily 3; PAS Domain Containing 3; Member Of PAS Protein 3; BHLH-PAS Protein JAP3; Mutant Basic Helix-Loop-Helix ARNT-Like Protein 1; Testis Tissue Sperm-Binding Protein Li 50e; Basic-Helix-Loop-Helix-PAS Orphan MOP3; ARNT-Like Protein 1, Brain And Muscle; BMAL1c; BHLHE5; TIC
Background

Gene Name: BMAL1

NCBI Gene Entry: 406

Storage Store at -80 °C for one year.
Kit Components 1. WB-Validated BMAL1 shRNA lentiviral particles (4 mL)
2. Non-Target shRNA lentiviral particles (4 mL)
3. Verification Tool: KD-Validated Anti-BMAL1 Mouse mAb #63424 (5 μL)
Tested Cell Line HeLa
Validation Methods RT-qPCR; Western Blotting (WB)
Shipping Shipped with dry ice. Immediately store the product in a standard freezer at -80°C upon receipt.
Instructions For Use The following protocol uses HeLa cell as an example assuming your cell culture medium is DMEM-based.
1.Release 0.5 million HeLa cells into a 35 mm tissue culture dish in 2 mL of the growth medium (DMEM containing 10% FBS and 1% pen/strep). Cell density should reach 50-60% confluence the following day.
2.24 h after cell release, pre-warm the shRNA lentiviral medium to 37°C.
3.Discard 1 mL of the original growth medium of the 35 mm dish.
4.Using a serological pipette, gently mix the lentiviral solution 3 times.
5.Carefully add 1 mL of the lentiviral solution to the well. Tip: To prevent splashing, add the solution to the dish along the wall.
6.Add a polybrene stock solution to the culture medium at a final concentration of 5 μg/mL. Gently swirl the dish to mix.
7.48 h after cell release, without discarding the original medium, add another 1 mL of lentiviral medium directly into the dish.
8.Add an additional polybrene stock solution into the dish to obtain a final concentration of 5 μg/mL. Tip: Now, the medium in the dish should be a total of 3 mL.
9.72 h after cell release, cells may reach confluence. Trypsinize the cells off the 35 mm dish and culture those cells in a 60 mm dish.
10.Add puromycin to the dish at a final concentration of 4 μg/mL. Tip: To assess the efficacy of puromycin selection, culture a dish of wild-type HeLa cells as a negative control.
11.Allow puromycin selection for 48 h. Almost all wild-type HeLa cells should die, while the dish infected with lentiviruses should have some remaining cells.
12.Replace the medium with regular growth medium without puromycin and allow the cells to grow to confluence before harvesting or staining.
Note 1. This product is for research use only.
2. This product is only supplied to end users.
3. Do not use this product for commercial.
Picture
  • RT-qPCR analysis. HeLa cells were infected with BMAL1-specific shRNA lentiviral particles, total RNA was extracted from wild-type and knockdown cells, RT-qPCR was performed using gene-specific primers. ∆Ct (CtKD-CtWT) was used to calculate mRNA reduction (%) between wild-type and knockdown cells using the following formula: (1-1/2∆Ct) x 100%.
  • Western blotting analysis. BMAL1 protein expression in wild-type (WT) and shRNA knockdown (KD) HeLa cells was detected using Western blotting. Hsp90 α served as a loading control. The blots were incubated with primary antibodies against BMAL1 and Hsp90 α, respectively, followed by incubating with HRP-conjugated goat anti-mouse secondary antibody. Images were developed using FeQ™ ECL Substrate Kit.
Citation(0)
RT-qPCR analysis. HeLa cells were infected with BMAL1-specific shRNA lentiviral particles, total RNA was extracted from wild-type and knockdown cells, RT-qPCR was performed using gene-specific primers. ∆Ct (CtKD-CtWT) was used to calculate mRNA reduction (%) between wild-type and knockdown cells using the following formula: (1-1/2∆Ct) x 100%.
Western blotting analysis. BMAL1 protein expression in wild-type (WT) and shRNA knockdown (KD) HeLa cells was detected using Western blotting. Hsp90 α served as a loading control. The blots were incubated with primary antibodies against BMAL1 and Hsp90 α, respectively, followed by incubating with HRP-conjugated goat anti-mouse secondary antibody. Images were developed using FeQ™ ECL Substrate Kit.
  • 联系电话

    0551-63635518

    0551-65578998

  • 联系邮箱

    support@genuinbiotech.cn

    sales@genuinbiotech.cn

微信公众号

Copyright © 2025 合肥善本生物科技有限公司

All Rights Reserved. 皖ICP备2023000814号